A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies
A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies
Recruiting · NCT06550713 · Registry updated 2024-08-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Trial of TQB3455 Tablets in Patients With Hematological Malignancies | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, bone marrow disorder, hematologic disorder, leukemia, myelodysplastic syndrome, myeloid leukemia, neoplasm | Recruiting | Phase 1 | 2024-08-13 | NCT06550713 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 88 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Harbin The First Hospital | Harbin | China | 2 |
| Peking University International Hospital | Beijing | China | 7 |
| Peking University People's Hospital | Beijing | China | 146 |
| People's Hospital of Tianjin | Tianjin | China | 3 |
| Shanghai Sixth People's Hospital | Shanghai | China | 1 |
| The Second Hospital of Hebei Medical University | Shijiazhuang | China | 30 |
| West China Hospital of Sichuan University | Chengdu | China | 117 |